-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Citizens
-
-
-
-
-
-
-
Zevra presents four-year MIPLYFFA data for rare disease treatment
-
-
-
-
-
-
-
Increasing unusual option volume: EWC CDLX ZVRA HPP UP BFLY LDI CBRL
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) Tops Q1 EPS by 18c
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Maxim Group
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $22 at Canaccord Genuity
-
429,440 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

